or Try an Advanced Search...

    Dystrophy Stocks List

    Symbol Grade Name % Change
    ELMD A Electromed, Inc. 0.20
    BNTC A Benitec Biopharma Limited 9.87
    SMMT B Summit Therapeutics plc -8.19
    SRPT B Sarepta Therapeutics, Inc. 2.35
    WVE B WAVE Life Sciences Ltd. 4.41
    PTCT B PTC Therapeutics, Inc. -0.60
    DYN C Dyne Therapeutics, Inc. -0.50
    TRDA C Entrada Therapeutics, Inc. -1.51
    SLDB C Solid Biosciences Inc. 7.23
    FULC D Fulcrum Therapeutics, Inc. 2.46
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Muscular Dystrophy Duchenne Duchenne Muscular Dystrophy Biopharmaceutical Disease Biotechnology Medicine Biology Dystrophin Genetic Genealogy Medical Genetics Cystic Fibrosis Cytoskeleton Facioscapulohumeral Muscular Dystrophy Gene Expression Huntington's Disease Infectious Diseases Life Sciences Myotonic Dystrophy Rare Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Dystrophy stocks.

    Symbol Grade Name Weight
    LABD C Direxion Daily S&P Biotech Bear 3X Shares 2.2
    SBIO C ALPS Medical Breakthroughs ETF 2.07
    BBP C BioShares Biotechnology Products Fund 1.9
    IBRN C iShares Neuroscience and Healthcare ETF 1.48
    BBC C Virtus LifeSci Biotech Clinical Trials ETF 1.19
    View all Dystrophy ETFs...
    Compare ETFs
    Compare LABD to BBP Compare LABD to IBRN Compare SBIO to BBP

        Dystrophy Stocks Recent News

        Date Stock Title
        May 2 SMMT Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
        May 2 WVE Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
        May 2 SRPT Q1 2024 Sarepta Therapeutics Inc Earnings Call
        May 2 SRPT Sarepta Therapeutics Inc (SRPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
        May 2 SMMT Summit Therapeutics Inc (SMMT) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
        May 2 SMMT Q1 2024 Summit Therapeutics Inc Earnings Call
        May 2 SMMT Summit Therapeutics Inc. (SMMT) Q1 2024 Earnings Call Transcript
        May 1 SRPT Sarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
        May 1 SRPT Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript
        May 1 SRPT Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript
        May 1 SRPT Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates
        May 1 SRPT Sarepta Therapeutics jumps 5% on Q1 beats
        May 1 SRPT Sarepta Therapeutics Non-GAAP EPS of $0.73 beats by $0.43, revenue of $413.5M beats by $43.02M
        May 1 SRPT Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
        May 1 PTCT PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
        May 1 SRPT 1 Top Growth Stock to Buy and Hold for 10 Years
        May 1 BNTC Benitec Biopharma to Participate in the Citizens JMP Life Science Conference
        May 1 SMMT Summit Therapeutics Non-GAAP EPS of -$0.05 beats by $0.01
        May 1 SMMT Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024
        Apr 30 SRPT Sarepta Therapeutics Q1 2024 Earnings Preview
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Genetic Genealogy Medical Genetics Medicine Rare Diseases Cytoskeleton Dystrophin Summit Acid Antibiotics Biopharmaceutical Biotechnology Caregiver Cdi Channelopathies Childhood Clinical Development Clostridioides Difficile
        Dystrophy

        Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

        More about Dystrophy
        Browse All Tags